16-74888302-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_030581.4(WDR59):c.2213G>A(p.Arg738Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000448 in 1,613,176 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_030581.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR59 | NM_030581.4 | c.2213G>A | p.Arg738Gln | missense_variant | 22/26 | ENST00000262144.11 | NP_085058.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR59 | ENST00000262144.11 | c.2213G>A | p.Arg738Gln | missense_variant | 22/26 | 5 | NM_030581.4 | ENSP00000262144.6 | ||
WDR59 | ENST00000563797.5 | c.289-547G>A | intron_variant | 3 | ENSP00000455060.1 | |||||
WDR59 | ENST00000567018.5 | n.475G>A | non_coding_transcript_exon_variant | 4/4 | 3 | |||||
WDR59 | ENST00000569788.5 | n.747G>A | non_coding_transcript_exon_variant | 5/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000382 AC: 58AN: 151990Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000276 AC: 69AN: 249934Hom.: 0 AF XY: 0.000230 AC XY: 31AN XY: 135070
GnomAD4 exome AF: 0.000455 AC: 665AN: 1461070Hom.: 1 Cov.: 34 AF XY: 0.000444 AC XY: 323AN XY: 726792
GnomAD4 genome AF: 0.000381 AC: 58AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74380
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at